Wilkinson Global Asset Management LLC Abbott Laboratories Transaction History

Wilkinson Global Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $173,705 - $212,630	1,926 New	1,926 $211,000
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $188,313 - $220,921	1,981 New	1,981 $217,000
Q2 2022 Jul 26, 2022	SELL	$102.07 - $123.37 $15,310 - $18,505	-150 Reduced 7.04%	1,981 $215,000
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $68,412 - $83,424	-600 Reduced 21.97%	2,131 $252,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $68,162 - $83,461	590 Added 27.56%	2,731 $384,000
Q1 2021 Apr 28, 2021	BUY	$108.84 - $128.23 $233,026 - $274,540	2,141 New	2,141 $257,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Wilkinson Global Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wilkinson Global Asset Management LLC with notifications on news.